Thymosin Alpha 1

$169.00

You’ll be briefly redirected to Link Money, our secure ACH payment partner, to connect your bank and complete payment.– Your bank login is never visible to or stored by us – Encrypted, bank-level security – A standard, trusted payment process

Aion Aminos

Precision Peptides for Advanced Research

Thymosin Alpha 1 is a synthetic version of a naturally occurring thymic peptide fragment composed of 28 amino acids. This thymosin alpha 1 peptide is derived from prothymosin alpha and belongs to the broader thymosin family of regulatory peptides associated with the immune system. In laboratory environments, thymosin alpha 1 is studied for its role in immune system signaling pathways and interactions with various immune-related cells. Research often explores how thymosin α1 influences immune response, immune modulation, and communication among immune cells, including t cell populations, dendritic cell signaling pathways, and natural killer cells. Scientific publications reference experimental investigations examining molecular mechanisms related to immune regulation, cytokine signaling, and pathways associated with inflammation and immune homeostasis. These investigations frequently explore receptor-mediated signaling networks affecting cellular communication within the immune system. This compound is supplied as a stable, research-grade lyophilized powder for controlled laboratory investigation.

Research Applications (Laboratory Use Only)

In laboratory environments, thymosin alpha 1 is widely studied for its role in immune system signaling and immune-related cellular communication. Research literature often examines how thymosin α1 interacts with immune-related cells, particularly t cell populations, to investigate mechanisms of immune regulation and immune signaling pathways.

Experimental studies explore how thymosin alpha peptides influence cytokine expression, immune response, and cellular signaling networks involved in immune modulation. Investigations frequently analyze pathways related to inflammation, immune suppression, and immune system adaptation in various cellular models.

Academic research also references experimental frameworks examining chronic infections, chronic viral infection, and viral infections, including studies involving hepatitis B and chronic hepatitis models. These references remain confined strictly to laboratory and research contexts and do not represent approved medical use.

Additional studies explore theoretical mechanisms involving immune surveillance, cellular communication between immune cells, and interactions with tumor cell signaling pathways in experimental models involving cancer cells. Research may also explore relationships between immune signaling and conditions such as autoimmune disease or autoimmune conditions in cellular research models.

Features & Chemical Makeup

  • Synthetic thymosin alpha 1 peptide composed of 28 amino acids

  • Member of the thymosin family derived from prothymosin alpha

  • Classified as a laboratory-grade research peptide

  • Studied for involvement in immune system signaling pathways

  • Investigated in laboratory models examining immune response and immune regulation

  • Explored in studies analyzing t cell function, dendritic cell signaling, and immune cell communication

  • Research literature references links with other thymic peptides such as thymosin beta 4 and thymosin fraction components

  • Investigated in cellular models examining inflammatory signaling and chronic inflammation pathways

  • Explored in studies involving immune surveillance, cytokine signaling, and immune system communication among cells

  • Supplied as a lyophilized powder for laboratory research

  • Distributed for research applications within the United States

Not intended for thymosin alpha 1 therapy, peptide therapy, or human consumption

Frequently Asked Questions

Thymosin Alpha 1 is a synthetic peptide derived from prothymosin alpha, consisting of 28 amino acids and studied in laboratory environments for its role in immune system signaling.

Scientific literature commonly references thymosin alpha1 in studies examining immune response, t cell function, cytokine signaling, and cellular communication among immune-related cells.

Although scientific literature may reference peptide therapy or thymosin alpha 1 therapy, this product is supplied strictly for research purposes and is not intended for therapeutic use.

No. This product is not intended for human consumption and is not designed to diagnose, treat, cure, or prevent infection, immune deficiency, or any other condition.

More Peptides